Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping

BACKGROUND: Vigilant management of women with high-risk human papillomavirus (hrHPV) is necessary in cancer screening programs. To this end, we evaluated the performance of S5 (targeting DNA methylation in HPV16, HPV18, HPV31, HPV33, and human gene EPB41L3) to predict cervical intraepithelial neopla...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Epigenetics
Hlavní autoři: Hernández-López, Rubí, Lorincz, Attila T., Torres-Ibarra, Leticia, Reuter, Caroline, Scibior-Bentkowska, Dorota, Warman, Rhian, Nedjai, Belinda, Mendiola-Pastrana, Indira, León-Maldonado, Leith, Rivera-Paredez, Berenice, Ramírez-Palacios, Paula, Lazcano-Ponce, Eduardo, Cuzick, Jack, Salmerón, Jorge
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6790057/
https://ncbi.nlm.nih.gov/pubmed/31606044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-019-0743-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky